Lynx1 Capital Management LP: CG ONCOLOGY INC (CGON): Quarterly 13F Position History
As of Q2 2026, Lynx1 Capital Management LP reported 31,391 shares of CG ONCOLOGY INC (CGON), worth $2.2M and representing 0.4% of its 13F equity book. Quarter-over-quarter share count change: 200 (-0.6%) . The position first appeared in Q4 2025 and has been disclosed across 3 13F-HR filings in Pactolio's tracked window.
- 31,391Shares Held (Latest Filing)
- $2.2MReported Market Value (Latest Filing)
- 0.4%Portfolio Weight (% of 13F Equity Book)
- 200Quarter-over-Quarter Share Change
- +$92.3KQuarter-over-Quarter Value Change
- 31,591Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 3 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 31,391 | 200 | -0.6% | $2.2M | 0.4% | $71.0 |
| Q1 2026 | 31,591 | 0 | – | $2.1M | 0.3% | $67.7 |
| Q4 2025 | 31,591 | – | – | $1.3M | 0.3% | $41.5 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Lynx1 Capital Management LP first disclose a CGON position in 13F-HR filings?
Lynx1 Capital Management LP first reported CG ONCOLOGY INC (CGON) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 3 reported quarters within Pactolio's tracked window.
What was Lynx1 Capital Management LP's most recent quarter-over-quarter share-count change in CGON?
Between Q1 2026 and Q2 2026, Lynx1 Capital Management LP reduced its CGON position by 200 shares (-0.6%), leaving 31,391 shares at a market value of $2.2M.
Does the implied price-per-share represent Lynx1 Capital Management LP's cost basis in CGON?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.